3/05/2013 - BioReliance Acquires Rights to Big Blue® Colonies and Cell Lines from Agilent
ST LOUIS, MO – March 5, 2013 – Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that BioReliance® (http://www.bioreliance.com), the biologics and early development services business under SAFC® (www.safcglobal.com), has signed an agreement to acquire the colonies required for the Big Blue® transgenic rodent mutation (TRM) assay and to obtain a license to its associated trademark from Agilent Technologies.